Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Top Cited Papers
Open Access
- 24 May 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 10 (1), 1-12
- https://doi.org/10.1186/1475-2875-10-144
Abstract
Quinine remains an important anti-malarial drug almost 400 years after its effectiveness was first documented. However, its continued use is challenged by its poor tolerability, poor compliance with complex dosing regimens, and the availability of more efficacious anti-malarial drugs. This article reviews the historical role of quinine, considers its current usage and provides insight into its appropriate future use in the treatment of malaria. In light of recent research findings intravenous artesunate should be the first-line drug for severe malaria, with quinine as an alternative. The role of rectal quinine as pre-referral treatment for severe malaria has not been fully explored, but it remains a promising intervention. In pregnancy, quinine continues to play a critical role in the management of malaria, especially in the first trimester, and it will remain a mainstay of treatment until safer alternatives become available. For uncomplicated malaria, artemisinin-based combination therapy (ACT) offers a better option than quinine though the difficulty of maintaining a steady supply of ACT in resource-limited settings renders the rapid withdrawal of quinine for uncomplicated malaria cases risky. The best approach would be to identify solutions to ACT stock-outs, maintain quinine in case of ACT stock-outs, and evaluate strategies for improving quinine treatment outcomes by combining it with antibiotics. In HIV and TB infected populations, concerns about potential interactions between quinine and antiretroviral and anti-tuberculosis drugs exist, and these will need further research and pharmacovigilance.Keywords
This publication has 98 references indexed in Scilit:
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in ZambiaMalaria Journal, 2010
- Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administrationBritish Journal of Clinical Pharmacology, 2010
- Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?The Lancet Infectious Diseases, 2009
- Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern CameroonMalaria Journal, 2009
- Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trialBMJ, 2009
- Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trialThe Lancet, 2009
- Quality of anti-malarial drugs provided by public and private healthcare providers in south-east NigeriaMalaria Journal, 2009
- In Vitro Monitoring of Plasmodium falciparum Drug Resistance in French Guiana: a Synopsis of Continuous Assessment from 1994 to 2005Antimicrobial Agents and Chemotherapy, 2008
- Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trialBMJ, 2006